Rates of active TB are rising nationally and particularly in London, many patients first presentation with active TB is with their GP. The national LTBI screening programme helps to offer treatment to a particular at-risk group (recent arrivals from high TB incidence countries) to reduce future risk of TB reactivation. However, inappropriate testing can lead to significant psychological impact. The management of exacerbations in Bronchiectasis differs from other respiratory conditions, lack of awareness of the national guidance on treatment, across the NHS, results in undertreatment of this patient population.
Speakers:
- Chris Carvalho – Lead GP/LTC Clinical Lead
- Dr Matt Burman – Consultant in Respiratory Medicine and clinical lead for Tuberculosis
Sessions
Respiratory Latent TB and Bronchiectasis Management
— Afternoon
Friday, 18th October 2024 / 1.00pm
Respiratory Latent TB and Bronchiectasis Management